HWAM
NUVB icon

Hennion & Walsh Asset Management’s Nuvation Bio NUVB Stock Holding History

Hennion & Walsh Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Sell
446,685
-3,909
-0.9% -$19.1K 0.07% 327
2026
Q1 		$1.93M Buy
450,594
+5,315
+1% +$29.6K 0.07% 362
2025
Q4 		$3.99M Buy
445,279
+106,008
+31% +$657K 0.14% 187
2025
Q3 		$1.26M Buy
339,271
+139,633
+70% +$381K 0.05% 459
2025
Q2 		$389K Buy
+199,638
New +$416K 0.02% 751

Other funds holding NUVB

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
FWP
Firethorn Wealth Partners Augusta, Georgia $310M AUM 23.22% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Hennion & Walsh Asset Management's NUVB Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Nuvation Bio (NUVB) stake by 0.87% in Q2 2026, selling an estimated $19.1K and leaving 446,685 shares worth $2.54M. The position accounts for 0.07% of the portfolio, ranked #327.

Hennion & Walsh Asset Management first reported a position in NUVB in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.99M in Q4 2025. 13 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Hennion & Walsh Asset Management held 446,685 shares of Nuvation Bio worth $2.54M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 3,909 Nuvation Bio shares in Q2 2026, an estimated $19.1K.
  • Nuvation Bio made up 0.07% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #327 holding.
  • Hennion & Walsh Asset Management first reported a position in Nuvation Bio in Q2 2025 and has held it in 5 quarters since.
  • Hennion & Walsh Asset Management's Nuvation Bio position peaked at $3.99M in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.